SEC Form 4 · accession 0001232524-18-000202
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
Dec 14, 2018
Accepted (ET)
Dec 14, 2018 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 14, 2018 | M | 3,295 | $46.83 | A | 44,518 | D | |
| Ordinary Shares | Dec 14, 2018 | S | 3,295 | $140.21 | D | 41,223 | D | |
| Ordinary Shares | Dec 14, 2018 | S | 39 | $140.21 | D | 41,184 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $46.83 | Dec 14, 2018 | M | 3,295 | D | — | Aug 8, 2022 | Ordinary Shares | 3,295 | 35,337 | D |
Explanation of responses
- F1Includes 173 ordinary shares acquired on May 31, 2018 and 72 shares acquired on November 30, 2018 under a Section 423 Employee Stock Purchase Plan.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3This non-qualified stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of August 9, 2012, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.